1. Home
  2. News
  3. Ben Tre Pharmaceutical JSC
  4. DBT: Explanation for the reviewed interim separate financial statements 2026
More Ben Tre Pharmaceutical JSC news
Ben Tre Pharmaceutical JSCHOSE: DBT

DBT: Explanation for the reviewed interim separate financial statements 2026

Sep 3, 2026 at 5:34 AM EDT · Issued by Ben Tre Pharmaceutical JSC

Filed with HOSE · Sep 3, 2026 at 5:34 AM EDT · 2 pages · English and Vietnamese

On 6ix: 6ix.com/news/dbt-explanation-for-the-reviewed-interim-separate-financial-statements-2026

Ben Tre Pharmaceutical JSC on 6ix

Story so far

  • DBT: Explanation for the reviewed interim consolidated financial statements 2026Sep 3, 2026
  • DBT: Explanation of the fluctuation in profit after tax in Quarter 2.2026Jul 31, 2026

Earlier from Ben Tre Pharmaceutical JSC

  • DBT: Explanation for the reviewed interim consolidated financial statements 2026Sep 3
  • DBT: Approval of the credit limit at VietinBankAug 18
  • DBT: Change in the 28th Certificate of Enterprise RegistrationAug 13
  • DBT: Information on the Legal RepresentativeAug 10
  • DBT: Documents, Minutes and Resolution of the 2026 EGMJul 31

Later from Ben Tre Pharmaceutical JSC

  • DBT: Change in the 17th Certificate of Operation Registration for Ho Chi Minh BranchSep 17
  • DBT: Notification Insider trade - Nguyen Khac HanhSep 29
  • DBT: BAF Viet Nam Agriculture Joint Stock CompanyOct 4
  • DBT: Change in personnelOct 4
All Ben Tre Pharmaceutical JSC news releases↗

Follow Ben Tre Pharmaceutical JSC into a list and get an email when it puts out news.

Follow Ben Tre Pharmaceutical JSC
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer